Popular Articles

Stand Up To Cancer Funds Joint Effort By M. D. Anderson, Harvard, Memorial-Sloan-Kettering
A Dream Team of leading cancer researchers will accelerate development of drugs to attack a mutated molecular pathway that fuels endometrial, breast and ovarian cancers, funded by a three-year $15 million grant awarded today by Stand Up To Cancer.
generic viagra online
Secondary Prevention: Aspirin Combined With Dipyridamole Just As Effective As Clopidogrel; Endarterectomy Safer Than Angioplasty
In the area of secondary prevention as well - guarding against renewed events in patients who already suffered from a stroke or a TIA - Professor Ferro points to important new research: "In this patient population, the direct comparison between Clopidogrel and the combination of aspirin with extended release Dipyridamole did not reveal any difference between both strategies." Both approaches have proven to be slightly more effective than aspirin alone.
News of the day
Doctor And Nurse Shortages Plague U.S.
The nation"s struggles with physician and nurse shortages are evident as health care reform takes shape.
Cardiovascular

Patient Recall Rates May Be Decreased By Digital Mammography Plus Digital Breast Tomosynthesis

Nationally, about ten percent of women in the US are recalled for a second mammogram after an abnormality is detected on the first one - for most women this can be very stressful. However the use of digital breast tomosynthesis and full-field digital mammography combined may be associated with a substantial decrease in recall rate, according to a study performed at UPMC in Pittsburgh, PA. Some researchers believe that digital breast tomosynthesis depicts the breast tissue in a way which may allow radiologists to identify some tumors which could be missed with standard two-dimensional mammography. The study included 125 patients that were evaluated using a combined method of digital breast tomosynthesis and standard digital mammography. "The use of digital breast tomosynthesis and full-field digital mammography (FFDM) was associated with a 30% reduction in recall rate for cancer-free examinations that would have led to recall if FFDM had been used alone," said Jules H. Sumkin, MD, one of the authors of the study. "Patient recalls are problematic at multiple levels. Patients pay an emotional price and it is a sheer inconvenience having to go back for a second appointment. It is also problematic for imaging facilities because they are faced with the high cost of res required for the recalls," he said. "We are confident that recall rates could be decreased by adding breast tomosynthesis to FFDM," said Dr. Sumkin. Digital breast tomosynthesis is not yet FDA approved. This study appears in the August issue of the American Journal of Roentgenology. Click here for abstract. Heather Curry American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):